{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:13:42Z","timestamp":1761743622400},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T00:00:00Z","timestamp":1332288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2490-12-8","type":"journal-article","created":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T23:09:14Z","timestamp":1332457754000},"source":"Crossref","is-referenced-by-count":16,"title":["Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium"],"prefix":"10.1186","volume":"12","author":[{"given":"Maria E","family":"Goossens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Buntinx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Joniau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Ackaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Ameye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignace","family":"Billiet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Braeckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Breugelmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Darras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Dilen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieven","family":"Goeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Kellen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Tombal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siska","family":"Van Bruwaene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Van Cleyenbreuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Van der Aa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Vekemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Van Poppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice P","family":"Zeegers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,21]]},"reference":[{"key":"203_CR1","unstructured":"Cancer incidence in Belgium, 2008. Belgium Cancer registry, Brussels. 2011, [ http:\/\/kankerregister.nettools.be\/media\/docs\/StK_publicatie.pdf ]"},{"key":"203_CR2","volume-title":"Lyon, France: International Agency for Research on Cancer","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. 2010, [ http:\/\/globocan.iarc.fr ]"},{"key":"203_CR3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/BF03262330","volume":"21","author":"MF Botteman","year":"2003","unstructured":"Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R: The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003, 21: 1315-1330.","journal-title":"Pharmacoeconomics"},{"key":"203_CR4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1017\/S0007114508922522","volume":"100","author":"MP Rayman","year":"2008","unstructured":"Rayman MP, Infante HG, Sargent M: Food-chain selenium and human health: emphasis on intake. Br J Nutr. 2008, 100: 238-253.","journal-title":"Br J Nutr"},{"key":"203_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/07315724.2002.10719214","volume":"21","author":"PD Whanger","year":"2002","unstructured":"Whanger PD: Selenocompounds in plants and animals and their biological significance. J Am Coll Nutr. 2002, 21: 223-232.","journal-title":"J Am Coll Nutr"},{"key":"203_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0163-7258(98)00014-X","volume":"79","author":"GF Combs Jr","year":"1998","unstructured":"Combs GF, Gray WP: Chemopreventive agents: selenium. Pharmacol Ther. 1998, 79: 179-192. 10.1016\/S0163-7258(98)00014-X.","journal-title":"Pharmacol Ther"},{"key":"203_CR7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2174\/138955708785740625","volume":"8","author":"C Sanmartin","year":"2008","unstructured":"Sanmartin C, Plano D, Palop JA: Selenium compounds and apoptotic modulation: a new perspective in cancer therapy. Mini Rev Med Chem. 2008, 8: 1020-1031. 10.2174\/138955708785740625.","journal-title":"Mini Rev Med Chem"},{"key":"203_CR8","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00204-010-0595-8","volume":"84","author":"J Brozmanova","year":"2010","unstructured":"Brozmanova J, Manikova D, Vlckova V, Chovanec M: Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol. 2010, 84: 919-938. 10.1007\/s00204-010-0595-8.","journal-title":"Arch Toxicol"},{"key":"203_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2174\/138955708784567368","volume":"8","author":"R Naithani","year":"2008","unstructured":"Naithani R: Organoselenium compounds in cancer chemoprevention. Mini Rev Med Chem. 2008, 8: 657-668. 10.2174\/138955708784567368.","journal-title":"Mini Rev Med Chem"},{"key":"203_CR10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1442-2042.2006.01526.x","volume":"13","author":"E Kellen","year":"2006","unstructured":"Kellen E, Zeegers M, Buntinx F: Selenium is inversely associated with bladder cancer risk: a report from the Belgian case-control study on bladder cancer. Int J Urol. 2006, 13: 1180-1184. 10.1111\/j.1442-2042.2006.01526.x.","journal-title":"Int J Urol"},{"key":"203_CR11","first-page":"186","volume":"12","author":"M Torun","year":"1995","unstructured":"Torun M, Aldemir H, Yardim S: Serum selenium levels in various cancer types. Trace Elements and Electrocytes. 1995, 12: 186-190.","journal-title":"Trace Elements and Electrocytes"},{"key":"203_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1464-410X.2003.04729.x","volume":"93","author":"O Yalcin","year":"2004","unstructured":"Yalcin O, Karatas F, Erulas FA, Ozdemir E: The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU Int. 2004, 93: 863-866. 10.1111\/j.1464-410X.2003.04729.x.","journal-title":"BJU Int"},{"key":"203_CR13","first-page":"103","volume":"79","author":"A Nomura","year":"1987","unstructured":"Nomura A, Heilbrun LK, Morris JS, Stemmermann GN: Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J Natl Cancer Inst. 1987, 79: 103-108.","journal-title":"J Natl Cancer Inst"},{"key":"203_CR14","first-page":"6144","volume":"49","author":"KJ Helzlsouer","year":"1989","unstructured":"Helzlsouer KJ, Comstock GW, Morris JS: Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res. 1989, 49: 6144-6148.","journal-title":"Cancer Res"},{"key":"203_CR15","first-page":"1292","volume":"11","author":"MP Zeegers","year":"2002","unstructured":"Zeegers MP, Goldbohm RA, Bode P, van den Brandt PA: Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11: 1292-1297.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"203_CR16","first-page":"1505","volume":"11","author":"DS Michaud","year":"2002","unstructured":"Michaud DS, Hartman TJ, Taylor PR, Pietinen P, Alfthan G, Virtamo J, Albanes D: No Association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2002, 11: 1505-1506.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"203_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/sj.bjc.6602788","volume":"93","author":"DS Michaud","year":"2005","unstructured":"Michaud DS, De Vivo I, Morris JS, Giovannucci E: Toenail selenium concentrations and bladder cancer risk in women and men. Br J Cancer. 2005, 93: 804-806. 10.1038\/sj.bjc.6602788.","journal-title":"Br J Cancer"},{"key":"203_CR18","volume-title":"Book Selenium for preventing cancer","author":"G Dennert","year":"2011","unstructured":"Dennert G, Zwahlen M, Brinkman M, Vinceti M, Zeegers Maurice PA, Horneber M: Selenium for preventing cancer. Book Selenium for preventing cancer. 2011, City: John Wiley & Sons, Ltd, (Editor ed.^eds.)"},{"key":"203_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1079\/BJN20041251","volume":"92","author":"MP Rayman","year":"2004","unstructured":"Rayman MP: The use of high-selenium yeast to raise selenium status: how does it measure up?. Br J Nutr. 2004, 92: 557-573. 10.1079\/BJN20041251.","journal-title":"Br J Nutr"},{"key":"203_CR20","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1046\/j.1464-410X.2003.04167.x","volume":"91","author":"AJ Duffield-Lillico","year":"2003","unstructured":"Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR, Clark LC: Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 2003, 91: 608-612. 10.1046\/j.1464-410X.2003.04167.x.","journal-title":"BJU Int"},{"key":"203_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.2008.864","volume":"301","author":"SM Lippman","year":"2009","unstructured":"Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, et al: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009, 301: 39-51. 10.1001\/jama.2008.864.","journal-title":"JAMA"},{"key":"203_CR22","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/jnci\/djp272","volume":"101","author":"ME Goossens","year":"2009","unstructured":"Goossens ME, Buntinx F, Zeegers MP: Re: Selenium and vitamin E: interesting biology and dashed hope. J Natl Cancer Inst. 2009, 101: 1363-1364. 10.1093\/jnci\/djp272. author reply 1364","journal-title":"J Natl Cancer Inst"},{"key":"203_CR23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S1470-2045(06)70862-2","volume":"7","author":"M Brinkman","year":"2006","unstructured":"Brinkman M, Buntinx F, Muls E, Zeegers MP: Use of selenium in chemoprevention of bladder cancer. Lancet Oncol. 2006, 7: 766-774. 10.1016\/S1470-2045(06)70862-2.","journal-title":"Lancet Oncol"},{"key":"203_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/03008880802284258","volume":"42","author":"HB Grossman","year":"2008","unstructured":"Grossman HB, Stenzl A, Moyad MA, Droller MJ: Bladder cancer: Chemoprevention, complementary approaches and budgetary considerations. Scand J Urol Nephrol. 2008, 42: 213-233.","journal-title":"Scand J Urol Nephrol"},{"key":"203_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s00120-007-1348-z","volume":"46","author":"JE Altwein","year":"2007","unstructured":"Altwein JE: [Primary prevention of bladder cancer. What's new?]. Urologe A. 2007, 46: 616-621. 10.1007\/s00120-007-1348-z.","journal-title":"Urologe A"},{"key":"203_CR26","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.juro.2006.07.004","volume":"176","author":"JE Busby","year":"2006","unstructured":"Busby JE, Kamat AM: Chemoprevention for bladder cancer. J Urol. 2006, 176: 1914-1920. 10.1016\/j.juro.2006.07.004.","journal-title":"J Urol"},{"key":"203_CR27","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1158\/1055-9965.EPI-10-0544","volume":"19","author":"AF Amaral","year":"2010","unstructured":"Amaral AF, Cantor KP, Silverman DT, Malats N: Selenium and bladder cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010, 19: 2407-2415. 10.1158\/1055-9965.EPI-10-0544.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"203_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1124\/mi.9.1.6","volume":"9","author":"DL Hatfield","year":"2009","unstructured":"Hatfield DL, Gladyshev VN: The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology. Mol Interv. 2009, 9: 18-21. 10.1124\/mi.9.1.6.","journal-title":"Mol Interv"},{"key":"203_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/jaoac\/87.1.225","volume":"87","author":"EH Larsen","year":"2004","unstructured":"Larsen EH, Hansen M, Paulin H, Moesgaard S, Reid M, Rayman M: Speciation and bioavailability of selenium in yeast-based intervention agents used in cancer chemoprevention studies. J AOAC Int. 2004, 87: 225-232.","journal-title":"J AOAC Int"},{"key":"203_CR30","first-page":"65","volume":"56","author":"W Oosterlinck","year":"2004","unstructured":"Oosterlinck W: Guidelines on diagnosis and treatment of superficial bladder cancer. Minerva Urol Nefrol. 2004, 56: 65-72.","journal-title":"Minerva Urol Nefrol"},{"key":"203_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.scitotenv.2008.06.024","volume":"400","author":"M Navarro-Alarcon","year":"2008","unstructured":"Navarro-Alarcon M, Cabrera-Vique C: Selenium in food and the human body: a review. Sci Total Environ. 2008, 400: 115-141. 10.1016\/j.scitotenv.2008.06.024.","journal-title":"Sci Total Environ"},{"key":"203_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/archinternmed.2009.495","volume":"170","author":"JK MacFarquhar","year":"2010","unstructured":"MacFarquhar JK, Broussard DL, Melstrom P, Hutchinson R, Wolkin A, Martin C, Burk RF, Dunn JR, Green AL, Hammond R, et al: Acute selenium toxicity associated with a dietary supplement. Arch Intern Med. 2010, 170: 256-261. 10.1001\/archinternmed.2009.495.","journal-title":"Arch Intern Med"},{"key":"203_CR33","first-page":"77","volume":"3","author":"G Yang","year":"1989","unstructured":"Yang G, Zhou R, Yin S, Gu L, Yan B, Liu Y, Li X: Studies of safe maximal daily dietary selenium intake in a seleniferous area in China I. Selenium intake and tissue selenium levels of the inhabitants. J Trace Elem Electrolytes Health Dis. 1989, 3: 77-87.","journal-title":"J Trace Elem Electrolytes Health Dis"},{"key":"203_CR34","volume-title":"Dietary References Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids","author":"Food: and Nutrition Board - USA Institute of Medicine","year":"2000","unstructured":"Food: and Nutrition Board - USA Institute of Medicine: Dietary References Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. 2000, Washington: National Academy Press"},{"key":"203_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","volume":"56","author":"PU Malmstrom","year":"2009","unstructured":"Malmstrom PU, Sylvester RJ, Crawford DE, Friedrich M, Krege S, Rintala E, Solsona E, Di Stasi SM, Witjes JA: An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer. Eur Urol. 2009, 56: 247-256. 10.1016\/j.eururo.2009.04.038.","journal-title":"Eur Urol"},{"key":"203_CR36","first-page":"8","volume":"8","author":"VR Ashughyan","year":"2006","unstructured":"Ashughyan VR, Marihart S, Djavan B: Chemopreventive trials in urologic cancer. Rev Urol. 2006, 8: 8-13.","journal-title":"Rev Urol"},{"key":"203_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-5347(17)34863-2","volume":"151","author":"DL Lamm","year":"1994","unstructured":"Lamm DL, Riggs DR, Shriver JS, Van Gilder PF, Rach JF, DeHaven JI: Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol. 1994, 151: 21-26.","journal-title":"J Urol"},{"key":"203_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/jcb.240501328","volume":"16I","author":"GR Prout Jr","year":"1992","unstructured":"Prout GR, Barton BA: 13-cis-retinoic acid in chemoprevention of superficial bladder cancer. The National Bladder Cancer Group. J Cell Biochem Suppl. 1992, 16I: 148-152.","journal-title":"J Cell Biochem Suppl"},{"key":"203_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1158\/1078-0432.CCR-07-0733","volume":"14","author":"AL Sabichi","year":"2008","unstructured":"Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, et al: Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008, 14: 224-229. 10.1158\/1078-0432.CCR-07-0733.","journal-title":"Clin Cancer Res"},{"key":"203_CR40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000475068","volume":"28","author":"UE Studer","year":"1995","unstructured":"Studer UE, Jenzer S, Biedermann C, Chollet D, Kraft R, von Toggenburg H, Vonbank F: Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland. Eur Urol. 1995, 28: 284-290.","journal-title":"Eur Urol"},{"key":"203_CR41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000475139","volume":"27","author":"DW Newling","year":"1995","unstructured":"Newling DW, Robinson MR, Smith PH, Byar D, Lockwood R, Stevens I, De Pauw M, Sylvester R: Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group. Eur Urol. 1995, 27: 110-116.","journal-title":"Eur Urol"},{"key":"203_CR42","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/0090-4295(77)90101-7","volume":"10","author":"D Byar","year":"1977","unstructured":"Byar D, Blackard C: Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology. 1977, 10: 556-561. 10.1016\/0090-4295(77)90101-7.","journal-title":"Urology"},{"key":"203_CR43","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.juro.2006.03.061","volume":"176","author":"E Messing","year":"2006","unstructured":"Messing E, Kim KM, Sharkey F, Schultz M, Parnes H, Kim D, Saltzstein D, Wilding G: Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer. J Urol. 2006, 176: 500-504. 10.1016\/j.juro.2006.03.061.","journal-title":"J Urol"},{"key":"203_CR44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.juro.2007.09.031","volume":"179","author":"S Naito","year":"2008","unstructured":"Naito S, Koga H, Yamaguchi A, Fujimoto N, Hasui Y, Kuramoto H, Iguchi A, Kinukawa N: Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer. J Urol. 2008, 179: 485-490.","journal-title":"J Urol"},{"key":"203_CR45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000475138","volume":"27","author":"Y Aso","year":"1995","unstructured":"Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S: Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol. 1995, 27: 104-109.","journal-title":"Eur Urol"},{"key":"203_CR46","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1464-410X.2009.08849.x","volume":"105","author":"MP Zeegers","year":"2009","unstructured":"Zeegers MP, Bryan RT, Langford C, Billingham L, Murray P, Deshmukh NS, Hussain S, James N, Wallace DM, Cheng KK: The West Midlands Bladder Cancer Prognosis Programme: rationale and design. BJU Int. 2009, 105: 784-788.","journal-title":"BJU Int"},{"key":"203_CR47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/00001813-200309000-00004","volume":"14","author":"MS Stratton","year":"2003","unstructured":"Stratton MS, Reid ME, Schwartzberg G, Minter FE, Monroe BK, Alberts DS, Marshall JR, Ahmann FR: Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study. Anticancer Drugs. 2003, 14: 595-600. 10.1097\/00001813-200309000-00004.","journal-title":"Anticancer Drugs"},{"key":"203_CR48","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/aje\/kwj097","volume":"163","author":"S Stranges","year":"2006","unstructured":"Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, Farinaro E, Clark LC, Reid ME: Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol. 2006, 163: 694-699. 10.1093\/aje\/kwj097.","journal-title":"Am J Epidemiol"},{"key":"203_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.7326\/0003-4819-147-4-200708210-00175","volume":"147","author":"S Stranges","year":"2007","unstructured":"Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, Reid ME: Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007, 147: 217-223.","journal-title":"Ann Intern Med"},{"key":"203_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.amjmed.2010.02.018","volume":"123","author":"AM Algotar","year":"2010","unstructured":"Algotar AM, Stratton MS, Stratton SP, Hsu CH, Ahmann FR: No effect of selenium supplementation on serum glucose levels in men with prostate cancer. Am J Med. 2010, 123: 765-768. 10.1016\/j.amjmed.2010.02.018.","journal-title":"Am J Med"},{"key":"203_CR51","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1289\/ehp.0900704","volume":"117","author":"M Laclaustra","year":"2009","unstructured":"Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E: Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ Health Perspect. 2009, 117: 1409-1413.","journal-title":"Environ Health Perspect"},{"key":"203_CR52","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/cncr.25641","volume":"117","author":"T MacKenzie","year":"2011","unstructured":"MacKenzie T, Zens MS, Ferrara A, Schned A, Karagas MR: Diabetes and risk of bladder cancer: evidence from a case-control study in New England. Cancer. 2011, 117: 1552-1556. 10.1002\/cncr.25641.","journal-title":"Cancer"},{"key":"203_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1743-7075-7-38","volume":"7","author":"KC Yang","year":"2010","unstructured":"Yang KC, Lee LT, Lee YS, Huang HY, Chen CY, Huang KC: Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study. Nutr Metab (Lond). 2010, 7: 38-10.1186\/1743-7075-7-38.","journal-title":"Nutr Metab (Lond)"},{"key":"203_CR54","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.numecd.2010.10.001","volume":"20","author":"S Stranges","year":"2010","unstructured":"Stranges S, Navas-Acien A, Rayman MP, Guallar E: Selenium status and cardiometabolic health: state of the evidence. Nutr Metab Cardiovasc Dis. 2010, 20: 754-760. 10.1016\/j.numecd.2010.10.001.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"203_CR55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/CIRCOUTCOMES.108.831552","volume":"2","author":"M Laclaustra","year":"2009","unstructured":"Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E: Serum selenium concentrations and hypertension in the US Population. Circ Cardiovasc Qual Outcomes. 2009, 2: 369-376. 10.1161\/CIRCOUTCOMES.108.831552.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"203_CR56","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/eurheartj\/ehl479","volume":"28","author":"TS Nawrot","year":"2007","unstructured":"Nawrot TS, Staessen JA, Roels HA, Den Hond E, Thijs L, Fagard RH, Dominiczak AF, Struijker-Boudier HA: Blood pressure and blood selenium: a cross-sectional and longitudinal population study. Eur Heart J. 2007, 28: 628-633.","journal-title":"Eur Heart J"},{"key":"203_CR57","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.bbagen.2009.03.014","volume":"1790","author":"MP Rayman","year":"2009","unstructured":"Rayman MP: Selenoproteins and human health: insights from epidemiological data. Biochim Biophys Acta. 2009, 1790: 1533-1540. 10.1016\/j.bbagen.2009.03.014.","journal-title":"Biochim Biophys Acta"},{"key":"203_CR58","first-page":"187","volume":"8","author":"GQ Yang","year":"1995","unstructured":"Yang GQ, Xia YM: Studies on human dietary requirements and safe range of dietary intakes of selenium in China and their application in the prevention of related endemic diseases. Biomed Environ Sci. 1995, 8: 187-201.","journal-title":"Biomed Environ Sci"},{"key":"203_CR59","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.ejca.2007.04.011","volume":"43","author":"E Kellen","year":"2007","unstructured":"Kellen E, Zeegers MP, Dirx M, Houterman S, Droste J, Lawrence G, Truyers C, Bruckers L, Molenberghs G, Joniau S, Buntinx F: Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom. Eur J Cancer. 2007, 43: 1694-1700. 10.1016\/j.ejca.2007.04.011.","journal-title":"Eur J Cancer"},{"key":"203_CR60","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2217\/14796694.3.5.515","volume":"3","author":"E Kellen","year":"2007","unstructured":"Kellen E, Zeegers MP, Joniau S, Buntinx F: Examining the co-occurrence of bladder and prostate cancer: a worthwhile investigation?. Future Oncol. 2007, 3: 515-519. 10.2217\/14796694.3.5.515.","journal-title":"Future Oncol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2490-12-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-12-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-12-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-12-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T16:38:57Z","timestamp":1593880737000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/1471-2490-12-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,21]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1186\/1471-2490-12-8","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,21]]},"article-number":"8"}}